
Novo Nordisk inks $2.2B deal to develop weight-loss pill to rival Lilly’s orforglipron
Indianapolis-based Eli Lilly & Co. announced promising results from a large study of its own tablet in diabetes patients last month.
Indianapolis-based Eli Lilly & Co. announced promising results from a large study of its own tablet in diabetes patients last month.
The Zimmer Biomet Oxford Cementless Partial Knee System received FDA approval in November, although the implant has been used in more than 300,000 procedures outside the U.S.
The Swiss pharmaceutical and diagnostics giant said the move will establish the Indianapolis-based Roche Diagnostics site as a hub for manufacturing of its continuous glucose monitoring system.
The extended partnership holds the potential to be the largest industry-academic agreement of its kind in the United States, Purdue President Mung Chiang said.
The company has announced more than $50 billion in new U.S. manufacturing investments since 2020.
Chief Scientific Officer Dr. Daniel Skovronsky talked with the IBJ about his hopes for the Lilly Medicine Foundry, which the Indianapolis-based drugmaker broke ground on this week.
Officials from the Indianapolis-based drugmaker said the Lilly Medicine Foundry will help streamline the process of discovering new medicines and getting them to patients.
Greenfield-based Elanco Health on Monday announced the $295 million cash sale of future U.S. royalty and milestone rights for the human use of a medication typically used for dogs and cats.
The desire to preserve a girl’s flowing hair during brain surgery led to the development of a comb-like device that could help cranial surgery patients avoid having their heads shaved.
Indiana lawmakers discovered this legislative session that performing major financial surgery on multibillion-dollar nonprofit hospital systems is a motley and entangled task.
The test, one of the first of its kind, is designed to reach patients who may forgo traditional screening because of lack of access, past trauma or embarrassment.
The Carmel center, which opened Monday, has 17 infusion rooms, eight rooms for clinical visits, a procedure room and a pharmacy.
The drugmaker accuses Premier Weight Loss of risking patients’ health by selling altered, unsterile versions of its blockbuster drugs Mounjaro and Zepbound.
At least 14 states already cover the cost of GLP-1 medications for obesity treatment for patients on Medicaid. Indiana is not one of them.
Syra Health Corp. plans to offer stock on the over-the-counter market after the company failed to meet Nasdaq Stock Market’s price requirements for its shares.
The company said its goal is to reduce wait times for patients seeking access to specialists, creating more opportunities for early diagnosis and intervention.
Aside from building four new plants, Johnson & Johnson said that it will expand several existing sites.
Indianapolis has been awash in Big Ten logos amid the conference’s basketball tournaments. But Indy is home to another sort of Big Ten gathering—one focused on improving cancer research.
Speaking at IBJ’s Technology Power Breakfast on Monday, U.S. Sen. Todd Young of Indiana also discussed the challenge of striking a balance between encouraging innovation in artificial intelligence and developing necessary guardrails.
Indianapolis-based Eli Lilly and Co. launched LillyDirect a little more than a year ago and has been ramping up efforts to connect directly with consumers on the platform since.